From Casetext: Smarter Legal Research

Muhilddine v. Merck Company, Inc.

United States District Court, E.D. California
Jan 26, 2007
2:06-cv-2814-GEB-GGH (E.D. Cal. Jan. 26, 2007)

Opinion

2:06-cv-2814-GEB-GGH.

January 26, 2007


ORDER


Since it appears likely that this action will be transferred toIn re VIOXX Products Liability Litigation, Multidistrict Litigation Proceeding No. 1657 in the Eastern District of Louisiana ("MDL-1657"), in the interest of judicial economy, the pending motions are deemed withdrawn and all hearings on the motions vacated, with the understanding that the motions could be re-noticed for hearing in this Court if the action is not transferred to MDL-1657, or could be noticed in front of the judge assigned to MDL-1657 after the action is transferred.

Upon entry of this Order, further proceedings in this action are stayed pending a decision on whether this action will be transferred to MDL-1657, except that Defendant Merck Company, Inc. ("Defendant") shall file a status report no later than March 26, 2007, in which it explains the status of its effort to transfer this action to MDL-1657.

IT IS SO ORDERED.


Summaries of

Muhilddine v. Merck Company, Inc.

United States District Court, E.D. California
Jan 26, 2007
2:06-cv-2814-GEB-GGH (E.D. Cal. Jan. 26, 2007)
Case details for

Muhilddine v. Merck Company, Inc.

Case Details

Full title:ALI MUHILDDINE and BASSEMA MUHILDDINE, Plaintiffs, v. MERCK COMPANY, INC.…

Court:United States District Court, E.D. California

Date published: Jan 26, 2007

Citations

2:06-cv-2814-GEB-GGH (E.D. Cal. Jan. 26, 2007)